University of Minnesota 2015LS095 (MNCCTN006): Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women With Advanced Non-Small Cell Lung Cancer

Objective

This is a phase II therapeutic study of adding exemestane therapy in post-menopausal women with advanced non-small cell lung cancer (NSCLC) who are progressing while on treatment with an immune checkpoint antibody (pembrolizumab, atezolizumab, or nivolumab).

https://clinicaltrials.gov/ct2/show/NCT02666105

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Studies

Specialty

• Lung Cancer

Contact

Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahealth.org